Introduction: The SYNTAX trial showed that coronary artery bypass grafting remains the standard of treatment for left main and three-vessel coronary artery disease, with lower rates of major cardiac and cerebrovascular events and need for revascularisation at 12 months when compared to percutaneous coronary intervention. Surgery did, however, have a higher rate of stroke in the post-operative period (2.2% versus 0.6%) [
- Serruys P.W.
- Morice M.-C.
- Kappetein A.P.
- Colombo A.
- Holmes D.R.
- Mack M.J.
- et al.
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.
N Engl J Med. 2009; 360: 961-972
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Heart, Lung and Circulation
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.N Engl J Med. 2009; 360: 961-972
- Impact of aortic manipulation on incidence of cerebrovascular accidents after urgical myocardial revascularization.Ann Thorac Surg. 2002; 73: 1387-1393
© 2011 Published by Elsevier Inc.